Cargando…
Inhibition of Neovascularization and Inflammation in a Mouse Model of Corneal Alkali Burns Using Cationic Liposomal Tacrolimus
Eye drops account for more than 90% of commercialized ophthalmic drugs. However, eye drops have certain shortcomings, such as short precorneal retention time and weak corneal penetration. The requirement of frequent instillation of eye drops also causes poor patient compliance, which may lead to fur...
Autores principales: | Lin, Xueqi, Yu, Xuewen, Chen, Xiang, Sheng, Siting, Wang, Jingwen, Wang, Ben, Xu, Wen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8688995/ https://www.ncbi.nlm.nih.gov/pubmed/34950647 http://dx.doi.org/10.3389/fbioe.2021.791954 |
Ejemplares similares
-
Ocular Wnt/β-Catenin Pathway Inhibitor XAV939-Loaded Liposomes for Treating Alkali-Burned Corneal Wound and Neovascularization
por: Zhong, Yueyang, et al.
Publicado: (2021) -
Tacrolimus Loaded Cationic Liposomes for Dry Eye Treatment
por: Chen, Xiang, et al.
Publicado: (2022) -
Heparin-Modified Amniotic Membrane Combined With Growth Factors for Promoting Corneal Wound Healing After Alkali Burn
por: Zhao, Xuan, et al.
Publicado: (2020) -
The long-term effect of tacrolimus on alkali burn-induced corneal neovascularization and inflammation surpasses that of anti-vascular endothelial growth factor
por: Chen, Ling, et al.
Publicado: (2018) -
Rhamnazin attenuates inflammation and inhibits alkali burn-induced corneal neovascularization in rats
por: Yu, Yao, et al.
Publicado: (2018)